Global Prader-Willi Syndrome (PWS) Therapeutics Market Sizing, Prevalence, Pipeline Analysis 2019 - Opportunities and Forecast to 2024 - ResearchAndMarkets.com

DUBLIN--()--The "Global Prader-Willi Syndrome (PWS) Therapeutics Market: Sizing, Prevalence, Pipeline Analysis (2019 Edition): Opportunities and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering.

Prader-Willi Syndrome therapeutics market is projected to display a robust growth represented by a CAGR of 4.6% during 2019 - 2024.

The report presents a comprehensive pipeline assessment that includes DCCR (Soleno Therapeutics), Levolitide (Millendo Therapeutics) and Tesomet (Saniona). Also, the report analyzes the prevalence of PWS and profiles the leading companies operating in the PWS Therapeutics market.

Over the recent years, the Prader-Willi Syndrome market has been witnessing considerable growth directly on the back of the increasing number of diagnosed patient's population. Moreover, growing human growth hormone therapy coverage rate, surging awareness and increasing government involvement have been driving the market.

Further, expected launch of novel therapies, such as DCCR (Soleno Therapeutics), Livoletide (Millendo Therapeutics), Testomet (Saniona AB) among others are anticipated to fuel the market growth.

The report titled report Prader-Willi Syndrome (PWS) Therapeutics Market: Sizing, Prevalence, Pipeline Analysis (2019 Edition): Opportunities and Forecast (2019 - 2024) has covered and analyzed the potential of Prader-Willi Syndrome market and provides statistics and information on market size, shares and growth factors.

Scope of the Report

Global Prader-Willi Syndrome Market (Actual Period: 2017-2018, Forecast Period: 2019-2024)

  • Prader-Willi Syndrome Market - Size, Growth, Forecast
  • Prader-Willi Syndrome Market: Pipeline Analysis
  • DCCR (Soleno Therapeutics)
  • Levolitide (Millendo Therapeutics)
  • Tesomet (Saniona)

Other Report Highlights

  • Pipeline Analysis.
  • Competitive Landscape.
  • Product Benchmarking.
  • Market Dynamics - Drivers and Restraints.
  • Market Trends.
  • Porter Five Forces Analysis.
  • SWOT Analysis.
  • Company Analysis - Pfizer, Novartis, Novo Nordisk, Soleno Therapeutics, Saniona

Key Topics Covered:

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

3.1 Invest in Somatropin Biosimilar

3.2 Invest in Combination Therapy For PWS

4. Surgical Masks Product Outlook

5. Global Prader-Willi Syndrome Market: Growth and Forecast

5.1 By Value (2017-2018)

5.2 By Value (2019-2024)

6. Global Prader-Willi Syndrome Pipeline Analysis

6.1 DCCR Pipeline Analysis

6.2 Levolitide Pipeline Analysis

6.3 Tesomet Pipeline Analysis

7. Global Prader-Willi Syndrome Market, By Region

8. U.S.A Prader-Willi Syndrome Market

8.1 U.S.A Prader-Willi Syndrome Market Size (2017-2024F)

8.2 U.S.A Prader-Willi Syndrome Prevalence (2017-2024F)

9. Europe Prader-Willi Syndrome Market

9.1 Europe Prader-Willi Syndrome Market Size (2017-2024F)

9.2 Europe Prader-Willi Syndrome Prevalence (2017-2024F)

10. Japan Prader-Willi Syndrome Market

10.1 Japan Prader-Willi Syndrome Market Size (2017-2024F)

10.2 Japan Prader-Willi Syndrome Prevalence (2017-2024F)

11. Global Prader-Willi Syndrome Market - Competitive Landscape

12. Global Prader-Willi Syndrome Market - Product Benchmarking

13. Global Prader-Willi Syndrome Market: Market Dynamics

13.1 Global Prader-Willi Syndrome Market Drivers

13.2 Global Prader-Willi Syndrome Market Restrains

13.3 Global Prader-Willi Syndrome Market Trends

14. Porter Five Force Analysis

15. SWOT Analysis

16. Global Prader-Willi Syndrome Market: Regulatory Frameworks

17. Company Profiles

17.1 Pfizer

17.2 Novartis AG

17.3 Novo Nordisk

17.4 Soleno Therapeutics

17.4 Saniona

For more information about this report visit https://www.researchandmarkets.com/r/1qb7d4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900